Whether the U = U message is received with scepticism or not, it is clear it is radically challenging the stigma associated with HIV
“Undetectable = untransmittable” (U = U) is a public health campaign that summarises the scientific advances confirming that an undetectable human immunodeficiency virus (HIV) viral load means there is no risk of the sexual transmission of HIV. U = U was launched in 2016, with an international consensus statement from researchers, people with HIV and community partners, to summarise the science around HIV treatment to prevent transmission and improve the lives of people with HIV.1
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Prevention Access Campaign. Risk of sexual transmission of HIV from a person living with HIV who has an undetectable viral load — messaging primer and consensus statement. https://www.preventionaccess.org/consensus (viewed July 2021).
- 2. Vernazza P, Bernard EJ. HIV is not transmitted under fully suppressive therapy: the Swiss statement — eight years later. Swiss Med Wkly 2016; 146: w14246.
- 3. Vernazza P, Hirshcel B, Bernasconi E, et al. HIV‐infizierte Menschen ohne andere STD sind unter wirksamer antiretroviraler Therapie sexuell nicht infektiös. [HIV‐infected people without other STDs are not sexually infectious during effective antiretroviral therapy]. Schweizerische Ärztezeitung 2008; 89: 165–169.
- 4. Cohen MS, Chen YQ, McCauley M, et al. Antiretroviral therapy for the prevention of HIV‐1 transmission. N Engl J Med 2016; 375: 830–839.
- 5. Bavinton BR, Pinto AN, Phanuphak N, et al. Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study. Lancet HIV 2018; 5: e438–e447.
- 6. Rodger AJ, Cambiano V, Bruun T, et al. Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV‐positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study. Lancet 2019; 393: 2428–2438.
- 7. Rodger AJ, Cambiano V, Bruun T, et al. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV‐positive partner is using suppressive antiretroviral therapy. JAMA 2016; 316: 171–81.
- 8. Okoli C, Van de Velde N, Richman B, et al. Undetectable equals untransmittable (U = U): awareness and associations with health outcomes among people living with HIV in 25 countries. Sex Transm Infect 2021; 97: 18–26.
- 9. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine. Undetectable = Untransmittable: a guide for clinicians to discuss 2020. https://www.ashm.org.au/HIV/UequalsU/ (viewed Sept 2020).
- 10. Calabrese SK, Mayer KH. Stigma impedes HIV prevention by stifling patient–provider communication about U = U. J Int AIDS Soc 2020; 23: e25559.
- 11. Power J, Amir S, Brown G, et al. HIV Futures 9: quality of life among people living with HIV in Australia, monograph series number 116. Melbourne: La Trobe University, 2019. https://www.latrobe.edu.au/__data/assets/pdf_file/0007/1058614/HIV‐Futures‐9.pdf (viewed July 2021).
- 12. Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine. Updated Australian guidance for clinicians and other health care providers discussing undetectable = untransmittable (U = U) with people living with HIV 2018. https://ashm.org.au/news/updated‐australian‐guidance‐for‐health‐care‐providers‐and‐UU/ (viewed July 2021).
- 13. Grace D, Nath R, Parry R, et al. “.. if U equals U what does the second U mean?”: sexual minority men’s accounts of HIV undetectability and untransmittable scepticism. Cult Health Sex 2020; https://doi.org/10.1080/13691058.2020.1776397 [Epub ahead of print].
We thank Chinyere Okoli for their advice for this work.
James McMahon’s institution received funding for the conduct of clinical trials by Gilead, ViiV and Merck. Brent Allan is affiliated with the industry liaison forum of the International AIDS Society, which receives funding from Gilead, ViiV, Merck, Abbott and Janssen.